Looking ahead, revenue is forecast to grow 65% p.a. on average during the next 3 years, compared to a 21% growth forecast for ...
In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on Omega Therapeutics (OMGA – Research Report), ...
Raymond James downgraded Omega Therapeutics (OMGA) to Market Perform from Outperform. Published first on TheFly – the ultimate source ...
Omega Therapeutics Inc. says its CEO, Mahesh Karande, has decided to leave the company for what it called "personal reasons,” ...
周五,Piper Sandler调整了对Omega Therapeutics (NASDAQ:OMGA)股票的展望,将目标价从此前的$9下调至$4,同时维持对该股票的增持评级。该公司的分析是基于Omega Therapeutics最近的财务和临床更新。 Omega Therapeutics在2024年第三季度结束时拥有3040万美元的现金储备,预计可以支持其运营至2025年第二季度。 该公司的MY ...
英为财情Investing.com - Omega Therapeutics (NASDAQ: OMGA )星期四发布了第三季度的财报,数据显示,公司营收高于分析师的预期,每股收益低于分析师的预期。 在该公司发布的最新财报中,公司每股收益为$-0.300,总营收为$2.61M,而此前英为财情Investing.com对分析师的调查显示,分析师预期该公司的营收为$1.2M,每股收益为$-0.280.
VANCOUVER, BC / ACCESSWIRE / November 12, 2024 / Omega Pacific Resources Inc. (CSE:OMGA)(OTCQB:OMGPF)(FSE:Q0F) ("Omega Pacific" or the "Company") is pleased to announce the Company is exercising its o ...
VANCOUVER, BC / ACCESSWIRE / November 12, 2024 / Omega Pacific Resources Inc. (CSE:OMGA)(OTCQB:OMGPF)(FSE:Q0F) ("Omega ...